PRRX1 and hepatocellular carcinoma: In clinical contexts, PRRX1 has been associated to contradictory prognostic outcomes showing that high PRRX1 expression predicted improved overall survival in colorectal cancer and HCC [10, 12, 13], but was associated with metastasis and poor survival outcome in breast cancer [8].